{"id":"W3107960404","doi":"10.1097/cmr.0000000000000708","title":"Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)","year":2020,"lang":"en","type":"article","venue":"Melanoma Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Ipilimumab; Nivolumab; Medicine; Discontinuation; Expanded access; Internal medicine; Melanoma; Adverse effect; Oncology; Gastroenterology; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001228419,0.0002617126,0.0005768487,0.0002558834,0.0001933265,0.0003321762,0.000253299,0.0002588708,0.0005399527],"category_scores_gemma":[0.0008557009,0.0001527181,0.0004452067,0.0003023213,0.0001719712,0.0001974173,0.0001638087,0.0005208637,0.0001228991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006547297,"about_ca_system_score_gemma":0.0006416555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002167529,"about_ca_topic_score_gemma":0.005269801,"domain_scores_codex":[0.9995646,0.0002158229,0.00002650482,0.00006053074,0.0001006768,0.00003189658],"domain_scores_gemma":[0.9993904,0.0001739601,0.0001672054,0.00003993881,0.00007432207,0.0001541736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1762818,0.01283952,0.3256377,0.0007186913,0.002574999,0.0005858581,0.0003125947,0.004063521,0.05740731,0.0000854677,0.003825612,0.4156669],"study_design_scores_gemma":[0.0360758,0.2077589,0.7370343,0.0000862277,0.001579304,0.001025788,0.00006604136,0.003474843,0.006963687,0.00006597098,0.005832095,0.00003704514],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973844,0.001555207,0.0001227097,0.0000603072,0.000008061945,0.00009566472,0.0002201167,0.00002137928,0.0005321972],"genre_scores_gemma":[0.9977624,0.0007000322,0.0004134458,0.0001370929,0.00004686534,0.00007751943,0.0005405505,0.000004512877,0.0003174361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002167529,"threshold_uncertainty_score":0.006496608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04357598447339473,"score_gpt":0.357439831923591,"score_spread":0.3138638474501962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}